We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
826
Alumis Inc
ALMS
$3.57B
| $699K | 0.01% |
+232,942
| New | +$1.1M |
|
827
Revolution Medicines Inc Warrant
RVMDW
$105M
| $695K | 0.01% |
2,646,023
+39,303
| +2% | +$5.83K |
|
|
APLS
828
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $692K | 0.01% |
+40,000
| New | +$740K |
|
829
Franklin Resources
BEN
$17.3B
| $687K | ﹤0.01% |
+28,819
| New | +$594K |
|
830
NIO
NIO
$11.6B
| $687K | ﹤0.01% |
200,200
+100
| +0% | +$373 |
|
831
Nike
NKE
$62.6B
| $687K | ﹤0.01% |
+9,666
| New | +$580K |
|
832
Fox Class A
FOXA
$24.2B
| $686K | ﹤0.01% |
12,242
+3,543
| +41% | +$187K |
|
833
CALL
Palantir
PLTR
$313B
| $682K | ﹤0.01% |
5,000
-59,200
| -92% | -$6.94M |
|
834
CALL
Phillips 66
PSX
$82.8B
| $680K | ﹤0.01% |
5,700
| – | – |
|
835
F5
FFIV
$22.6B
| $676K | ﹤0.01% |
2,296
+606
| +36% | +$167K |
|
836
NiSource
NI
$22.1B
| $674K | ﹤0.01% |
16,719
+11,446
| +217% | +$449K |
|
837
Global E Online
GLBE
$6.42B
| $672K | ﹤0.01% |
+20,039
| New | +$676K |
|
|
NAK
838
Northern Dynasty Minerals
NAK
$863M
| $670K | ﹤0.01% |
+500,000
| New | +$558K |
|
839
Kimberly-Clark
KMB
$36.9B
| $659K | ﹤0.01% |
5,112
-2,186
| -30% | -$296K |
|
840
Micron Technology
MU
$993B
| $652K | ﹤0.01% |
5,294
-104,130
| -95% | -$9.73M |
|
841
PUT
GE Aerospace
GE
$375B
| $643K | ﹤0.01% |
2,500
-12,000
| -83% | -$2.63M |
|
842
ATI
ATI
$26.1B
| $640K | ﹤0.01% |
+7,409
| New | +$507K |
|
843
Fortune Brands Innovations
FBIN
$6.17B
| $640K | ﹤0.01% |
+12,423
| New | +$650K |
|
|
BULL
844
PUT
Webull Corp
BULL
$4.1B
| $637K | ﹤0.01% |
+53,300
| New | +$826K |
|
845
PUT
NRG Energy
NRG
$29.2B
| $626K | ﹤0.01% |
+3,900
| New | +$514K |
|
|
EVGOW
846
DELISTED
EVgo Inc Warrants
EVGOW
| $620K | ﹤0.01% |
2,819,066
| – | – |
|
|
CRGX
847
DELISTED
CARGO Therapeutics
CRGX
| $618K | ﹤0.01% |
150,000
| – | – |
|
848
CALL
ServiceNow
NOW
$110B
| $617K | ﹤0.01% |
3,000
-21,500
| -88% | -$4.06M |
|
849
Cadence Design Systems
CDNS
$93.9B
| $616K | ﹤0.01% |
+2,000
| New | +$582K |
|
850
CALL
DoorDash
DASH
$80.5B
| $616K | ﹤0.01% |
+2,500
| New | +$501K |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.